January Accessibility and Affordability Working Group Meeting
MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
ACCESSIBILITY AND AFFORDABILITY WORKING GROUP
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Date: January 13, 2023
Time: 2:30 p.m. to 4:00 p.m.
Meeting ID and Passcode has changed (see below)
This meeting of the Accessibility and Affordability Working Group will be conducted by teleconference only. None of the locations from which members will participate will be open to the public. Members of the public who wish to listen to the meeting may do so via telephone by dialing the number listed below. Members of the public who wish to comment during the meeting may do so by telephone or email, as described below.
Public Comment Instructions
Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:
- Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
- Once we call your name you will have 3-minutes to make your public comment; please remember to be respectful of the time limit.
- Written comment may be sent to the following email address: email@example.com.
Dial in number: (669) 900 6833
876 0624 0937 851 1877 7092
- Call to Order
- Roll Call
- Update on CIRM Clinical Portfolio Update
- Update on Continuation of Medical Affairs Roadmap for Accessibility and Affordability
- Public comment
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Marivel De La Torre at the California Institute for Regenerative Medicine at (415) 769-8730 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Accessibility and Affordability Working Group meeting may be referred to Marivel De La Torre at the California Institute for Regenerative Medicine at firstname.lastname@example.org or (415) 769-8730.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.